Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.
about
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individualsContinue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol.Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia.Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract.Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesionsFecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and complianceAre medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literatureColorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysisThe impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.Warfarin Use During Fecal Occult Blood Testing: A Meta-Analysis.Prevalence of significant neoplasia in FOBT-positive patients on warfarin compared with those not on warfarin.Effect of oral anticoagulants on the outcome of faecal immunochemical test.Organized colorectal cancer screening in integrated health care systems.Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review.Colorectal cancer screening--optimizing current strategies and new directions.Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?Programmatic screening for colorectal cancer: the COLONPREV study.Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis.Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?Colorectal Cancer Screening: A Comprehensive Review to Recent Non-Invasive Methods.Antithrombotic drug does not affect the positive predictive value of an immunochemical fecal occult blood test.Sex differences in performance of fecal occult blood testing.Faut-il restreindre la médication avant une RSOS?: Conseils pratiques fondés sur une synthèse critique de la littérature médicale.Delayed sample arrival at the laboratory does not lead to more false negatives in the Danish population screening for colorectal cancer.Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia.Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.The "Iowa get screened" colon cancer screening program.Small bowel evaluation in asymptomatic fecal immunochemical test-positive patients with a negative colonoscopy: is it necessary?Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms
P2860
Q24235071-3EF17644-6217-4531-B6F7-A317396DFF51Q28292502-B603D6EF-4AE5-4B20-9DA6-701962979D9CQ33945977-2E2E31EA-3DE4-4F10-83EC-118E199A02D4Q35034632-32C50678-E0FB-44AE-A467-CB83C5A25196Q35223526-82DF9654-5DDA-4228-A648-AD1759A3C2A9Q35983252-FA3E4052-3C99-4A19-A909-189D175D42F7Q36137778-BCF5AF78-B661-4F1D-8C69-FA7B020273A3Q36229548-DED22F6A-0B28-4C8B-B081-306115506A65Q36500818-5E61042E-04E5-470F-8CBC-8A4E844EB435Q36957761-06E34E69-44E5-4AFF-8B91-B47415557BD7Q37003382-14C8AF30-C0BA-4E90-BCB3-5228752628D3Q37311810-C5D6AFF0-00A4-4AE8-9C5E-7079E748F50DQ37457131-0A45C24B-9E4C-45DC-85B4-057216C9600CQ37632165-979CF1B1-B27C-487F-8CAA-6ADD472086BDQ37895029-12CFD29A-4C2F-4287-9EC2-0A36A2DE64B8Q37899886-73900AE0-34BD-4219-90DA-C113D35F1573Q38079126-E8CFA4F5-E3B4-4DFB-B90A-1009A6ADBDC0Q38091719-99E1D4B8-7F45-462A-AA0A-CB72F5D214D8Q38285934-DD4575F6-692B-4ABF-B60F-F11B16A60E6DQ38983778-3BC859D0-7790-4C63-A286-B8AFE0A124CCQ39051460-5DD8B625-CD6E-4B7A-84A8-12E3D8BC64A1Q40791146-A5352F9E-F83F-4195-B0D6-9A3E992C09B1Q42229907-BF12FB98-60EF-4429-B3A2-9F6A2F3A583BQ43990041-E8F2FD7A-A970-4D73-AECE-DB3818147841Q44703721-13C44B97-E416-42E8-8B50-EB9585AE0F30Q46968402-953CEB88-B447-4258-9EE8-A3652412B6CDQ47949172-A913CDBF-BAC1-4083-8F70-59C89DDAE6F2Q49615161-8B66A17B-6F43-4481-8B58-FA01475C4F26Q51199086-94ADAFD3-6092-4DC8-A8B9-DB5BD8999166Q51776293-B7F2CE71-9BDD-478A-A5DB-0227FE3943C9Q53413120-61DA18F0-47A6-430B-BDAE-2DEC67C9CF7EQ57151140-750B2681-E2C4-4EAE-AB1E-85498F975E7B
P2860
Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Sensitivity, but not specifici ...... n, NSAIDs, and anticoagulants.
@en
Sensitivity, but not specifici ...... n, NSAIDs, and anticoagulants.
@nl
type
label
Sensitivity, but not specifici ...... n, NSAIDs, and anticoagulants.
@en
Sensitivity, but not specifici ...... n, NSAIDs, and anticoagulants.
@nl
prefLabel
Sensitivity, but not specifici ...... n, NSAIDs, and anticoagulants.
@en
Sensitivity, but not specifici ...... n, NSAIDs, and anticoagulants.
@nl
P2093
P921
P356
P1476
Sensitivity, but not specifici ...... n, NSAIDs, and anticoagulants.
@en
P2093
Alex Vilkin
Amal Waked
Nicky Lieberman
Paul Rozen
Rachel Hazazi
Shlomo Birkenfeld
Shmuel Klang
P304
P356
10.1038/AJG.2009.14
P407
P50
P577
2009-03-17T00:00:00Z